跳至主要内容
临床试验/NCT07247812
NCT07247812招募中不适用

The Effects of Transcutaneous Spinal Cord Stimulation on Upper Extremity Function in Children and Young People With Hemiplegic Cerebral Palsy

University of Leeds2 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2026年4月29日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
18
试验地点
2
主要终点
Participants with stimulation-site skin reaction (Yes/No; photographic assessment)

研究概览

简要总结

This work will examine if a technique called Transcutaneous Spinal cord stimulation (tSCS), when used with concurrent specific arm and hand exercises, helps improve arm and hand movements in CYP with HCP.

Does Transcutaneous Spinal Cord Stimulation (tSCS), when combined with specific arm and hand exercises, improve upper limb function in children and young people (CYP) with Hemiplegic Cerebral Palsy (HCP)?

-To determine the feasibility and effectiveness of Transcutaneous Spinal Cord Stimulation (tSCS) combined with targeted arm and hand exercises in improving the upper limb function in children and young people with Hemiplegic Cerebral Palsy (HCP).

详细描述

Cerebral palsy (CP) is a condition that affects movement and posture due to brain development issues in babies or young children. Hemiplegic CP (HCP) is a condition where one side of the body is paralysed. Symptoms like stiffness in the arms and legs usually appear early and can make everyday tasks, such as reaching or holding objects difficult. Improving arm and hand function is crucial for increasing independence and quality of life for children with HCP. This study investigates a technique called Transcutaneous Spinal Cord Stimulation (tSCS). tSCS uses sticky pads placed on the skin to deliver a mild electrical current. This current stimulates nerves to help them send signals to the muscles, potentially improving arm and hand movements. Research has demonstrated that tSCS can provide benefits in the lower limb for children and young people (CYP) with CP, those with spinal cord injuries and healthy individuals. In this project, we will test the feasibility and effectiveness of tSCS in 18 CYP (aged 12-21 years) with HCP. The participant will attend two sessions. Each session will last approximately 60-90 minutes and will include:

  • A Baseline Assessment (before training)
  • A 30-minute Upper Limb Task Training (ULTT)
  • One session will involve transcutaneous spinal cord stimulation (tSCS) combined with ULTT
  • One session will involve ULTT only (no stimulation)
  • The order is randomised, meaning participants do the stimulation session first or second
  • A Post-Training Assessment

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age and Gender: Boys and girls aged 12 to 21 years.
  • Diagnosis: Are diagnosed with Hemiplegic Cerebral Palsy (HCP).
  • Hand Function: Are experiencing difficulties with hand functions in daily activities.
  • Medical Stability: Have stable medical conditions without cardiopulmonary disease or seizures.
  • Motor Capability: Are capable of performing simple motor tasks such as reaching, touching, or grasping objects.
  • Availability: Are able to attend two sessions
  • Consent informed: Are able to provide informed consent (or if under 16, will need to have a parent or legal guardian who is willing to provide consent on their behalf).
  • Language: Are able to speak English (and if under 16, their parent or legal guardian must also be able to speak English)

排除标准

  • Other Neurological Conditions: Have neurological diseases other than cerebral palsy.
  • Blood Pressure: Have uncontrolled or high blood pressure.
  • Recent Surgeries: Have recently undergone significant surgeries (neurological, cardiac, respiratory, or metabolic) without sufficient recovery time.
  • Severe Diseases: Have cardiovascular or pulmonary diseases.
  • Medical Complications: Have ongoing medical complications such as unhealed fractures, contractures, or active infections or cancer.
  • Protocol Compliance: Are unable to follow study protocols safely.
  • Epilepsy History: Have a personal or family history of epilepsy.
  • Recent Injections: Have had botulinum toxin injections within the past six months.
  • Implanted Devices: Have implanted devices like pacemakers or baclofen pumps.
  • Exclusion of Participants with Recent Research Involvement: Participants who have taken part in any clinical research study within the last 3 months will be excluded.

研究组 & 干预措施

transcutaneous spinal cord stimulation (tSCS) combined with Upper Limb Training Task (ULTT)

Experimental

One session will involve transcutaneous spinal cord stimulation (tSCS) combined with ULTT

干预措施: Digimer DS8R (Device)

ULTT ONLY

No Intervention

one session with ULTT only (no stimulation; tSCS)

结局指标

主要结局

Participants with stimulation-site skin reaction (Yes/No; photographic assessment)

时间窗: At the first session: Baseline (pre-tSCS) and immediately post-tSCS

Standardised photographs of the back will be obtained at each time point and reviewed by an independent clinician (not part of the study team). A skin reaction is defined as any visible erythema at/near the electrode site and will be recorded on a Yes/No erythema scale (0 = No erythema; 1 = Yes erythema). Results will be reported as the number and proportion of participants with ≥1 skin reaction during the session and by time point.

Heart Rate Category (beats per minute)

时间窗: [Time Frame: Baseline (pre-tSCS); During tSCS (10 minutes after start); Immediately post-tSCS (within 10 minutes after end) during a single session.

Heart rate will be measured immediately before and after tSCS using an OMRON M3 device. For each participant, a blinded independent clinician will classify the post-stimulation change relative to Baseline as one of three categories: Increased, Decreased, or No Apparent Change. Study results will be summarised as the number and proportion of participants in each category and described narratively.

Hand Strength Index (dynamometry)

时间窗: Session 1[first visit]: Pre (Baseline, before tSCS); Session 1 [first visit]: Post (immediately after tSCS, within 10 minutes); Session 2 [second visit]: Pre (Baseline, before tSCS); Session 2 [sv]: Post (immediately after tSCS, within 10 minutes)

Handgrip and pinch strength will be measured with handheld dynamometers (adjustable handle/pads; peak-hold). At each time point, participants perform 3 maximal attempts per measure; the average (mean) is calculated for handgrip and for pinch. Results will be summarised as mean (SD) by timepoint and change from pre to post within each session (Post - Pre). Component means (handgrip and pinch) will be presented descriptively as supportive information.

Jebsen-Taylor Hand Function Test total time (seconds)

时间窗: Session 1[first visit]: Pre (Baseline, before tSCS); Session 1 [first visit]: Post (immediately after tSCS, within 10 minutes); Session 2 [second visit]: Pre (Baseline, before tSCS); Session 2 [sv]: Post (immediately after tSCS, within 10 minutes)

Hand function will be assessed with the Jebsen-Taylor Hand Function Test (JTHFT). The protocol includes three subtests: (1) picking up small common objects; (2) stacking checkers; (3) lifting large light and large heavy cans (\~1 lb). Each subtest is timed to completion. Testing is administered with the less affected hand first, then the more affected hand; the primary outcome is the Total Score for the more affected hand. Results will be summarised as mean (SD) seconds by timepoint and change from pre to post within each session (Post - Pre). (Scores for the less affected hand may be presented descriptively as supportive data.)

Muscle Activity: Mean motor threshold to elicit ≥50 µV sEMG response (mA) - Delsys Trigno / Digitimer DS8R

时间窗: Session 1: Pre (Baseline, before tSCS); Session 1: Post (immediately after tSCS, within 10 minutes); Session 2: Pre (Baseline, before tSCS); Session 2: Post (immediately after tSCS, within 10 minutes).

Muscle activity will be assessed with surface EMG (Delsys Trigno). Sensors will be placed on the more affected arm over the abductor pollicis brevis, flexor carpi radialis, and extensor carpi radialis longus. Single spinal pulses (1 ms biphasic square-wave) will be delivered every \~5 s using a Digitimer DS8R. For each muscle at each time point, the motor threshold is defined as the lowest stimulation amplitude (mA) that produces an evoked sEMG response ≥50 µV. The participant-level outcome is the mean motor threshold (mA) across the three muscles. Results will be summarised as mean (SD) mA by timepoint and change from Baseline to Post.

Modified Ashworth Scale (0-4; higher = worse) - worst upper-limb muscle score (more affected limb)

时间窗: Session 1[first visit]: Pre (Baseline, before tSCS); Session 1 [first visit]: Post (immediately after tSCS, within 10 minutes); Session 2 [second visit]: Pre (Baseline, before tSCS); Session 2 [sv]: Post (immediately after tSCS, within 10 minutes)

Spasticity will be assessed with the Modified Ashworth Scale (MAS), scored 0, 1, 1+, 2, 3, 4 (0 = no increase in tone; 4 = rigid; higher scores indicate worse spasticity). The following muscles on the more affected upper limb will be tested in a fixed order: elbow flexors, wrist flexors, finger flexors. At each timepoint, the primary outcome is the worst (highest) MAS score across the tested muscles. Results will be summarised as median by timepoint and change from Pre to Post within each session (Post - Pre).

Systolic Blood Pressure Category (mmHg)

时间窗: Baseline (pre-tSCS); During tSCS (10 minutes after start); Immediately post-tSCS (within 10 minutes after end) during a single session.

Systolic blood pressure will be measured immediately before and after tSCS using an OMRON M3 device. For each participant, a blinded independent clinician will classify the post-stimulation change relative to Baseline as one of three categories: Increased, Decreased, or No Apparent Change. Study results will be summarised as the number and proportion of participants in each category and described narratively.

Diastolic Blood Pressure Category (mmHg)

时间窗: Baseline (pre-tSCS); During tSCS (10 minutes after start); Immediately post-tSCS (within 10 minutes after end) during a single session.

Diastolic blood pressure will be measured immediately before and after tSCS using an OMRON M3 device. For each participant, a blinded independent clinician will classify the post-stimulation change relative to Baseline as one of three categories: Increased, Decreased, or No Apparent Change. Study results will be summarised as the number and proportion of participants in each category and described narratively.

次要结局

  • Participant-reported experience with stimulation - response frequencies (project-specific questionnaire)(Immediately post-final tSCS session [first session] (within 10 minutes), single administration.)
  • ABILHAND-Kids total raw score (0-42; higher = better manual ability)(Session 1[first visit]: Pre (Baseline, before tSCS); Session 1 [first visit]: Post (immediately after tSCS, within 10 minutes); Session 2 [second visit]: Pre (Baseline, before tSCS); Session 2 [sv]: Post (immediately after tSCS, within 10 minutes).)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Professor Sarah Astill

Professor

University of Leeds

研究点 (2)

Loading locations...

相似试验

tSCS in Children and Young People With HCP | 临床试验